Frontier Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Frontier Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-184,433	Closed	-$1.41M	–	258
2022 Q4	$1.41M	Buy	184,433 +902	+0.5%	+$7.02K	0.02%	254
2022 Q3	$1.31M	Sell	183,531 -51,114	-22%	-$481K	0.02%	259
2022 Q2	$1.9M	Sell	234,645 -362,228	-61%	-$3.18M	0.02%	270
2022 Q1	$8.29M	Buy	596,873 +404,561	+210%	+$6.36M	0.08%	225
2021 Q4	$5.4M	Buy	192,312 +126,722	+193%	+$3.88M	0.04%	253
2021 Q3	$2.23M	Sell	65,590 -37,296	-36%	-$1.35M	0.02%	269
2021 Q2	$4.2M	Sell	102,886 -133,701	-57%	-$5.2M	0.03%	274
2021 Q1	$9.53M	Sell	236,587 -460,371	-66%	-$24.9M	0.07%	227
2020 Q4	$41.2M	Sell	696,958 -119,709	-15%	-$6.17M	0.31%	129
2020 Q3	$39.7M	Buy	816,667 +61,205	+8%	+$2.57M	0.35%	107
2020 Q2	$36.5M	Sell	755,462 -191,248	-20%	-$6.97M	0.32%	110
2020 Q1	$26.3M	Buy	946,710 +618,353	+188%	+$17.2M	0.3%	114
2019 Q4	$9.82M	Buy	+328,357	New	+$9.43M	0.07%	223

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Frontier Capital Management's ADPT Position: Q1 2023 in Review

Frontier Capital Management sold out of Adaptive Biotechnologies (ADPT) in Q1 2023, closing a stake of 184,433 shares — an estimated $1.41M sold.

Frontier Capital Management first reported a position in ADPT in Q4 2019 and held it in 13 quarters. The position peaked at $41.2M in Q4 2020. 226 funds tracked by Wall St. Rank hold ADPT as of Q1 2023.

Frontier Capital Management reported no remaining Adaptive Biotechnologies position as of Q1 2023 after selling out during the quarter.
Frontier Capital Management sold 184,433 Adaptive Biotechnologies shares in Q1 2023, an estimated $1.41M.
Frontier Capital Management first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 13 quarters.
Frontier Capital Management's Adaptive Biotechnologies position peaked at $41.2M in Q4 2020.
226 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2023.

Based on Frontier Capital Management's 13F filing for Q1 2023, filed 15 May 2023.